Literature DB >> 33946919

Oral Administration of Lactobacillus rhamnosus Ameliorates the Progression of Osteoarthritis by Inhibiting Joint Pain and Inflammation.

JooYeon Jhun1,2, Keun-Hyung Cho1,2, Dong-Hwan Lee3, Ji Ye Kwon1, Jin Seok Woo1, Jiyoung Kim1, Hyun Sik Na1,2, Sung-Hwan Park4, Seok Jung Kim3, Mi-La Cho1,5.   

Abstract

Osteoarthritis (OA) is the most common form of arthritis and age-related degenerative joint disorder, which adversely affects quality of life and causes disability. However, the pathogenesis of OA remains unclear. This study was performed to examine the effects of Lactobacillus rhamnosus in OA progression. OA was induced in 6-week-old male Wistar rats by monosodium iodoacetate (MIA) injection, and the effects of oral administration of L. rhamnosus were examined in this OA rat model. Pain severity, cartilage destruction, and inflammation were measured in MIA-induced OA rats. The small intestines were isolated from OA rats, and the intestinal structure and inflammation were measured. Protein expression in the dorsal root ganglion was analyzed by immunohistochemistry. The effects of L. rhamnosus on mRNA and protein expression in chondrocytes stimulated with interleukin (IL)-1β and lipopolysaccharide (LPS) were analyzed by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Pain severity was decreased in L. rhamnosus-treated MIA-induced OA rats. The levels of expression of MCP-1, a potential inflammatory cytokine, and its receptor, CCR2, were decreased, and GABA and PPAR-γ expression were increased in L. rhamnosus-treated OA rats. The inflammation, as determined by IL-1β, and cartilage destruction, as determined by MMP3, were also significantly decreased by L. rhamnosus in OA rats. Additionally, intestinal damage and inflammation were improved by L. rhamnosus. In human OA chondrocytes, TIMP1, TIMP3, SOX9, and COL2A1 which are tissue inhibitors of MMP, and IL-10, an anti-inflammatory cytokine, were increased by L. rhamnosus. L. rhamnosus treatment led to decreased pain severity and cartilage destruction in a rat model of OA. Intestinal damage and inflammation were also decreased by L. rhamnosus treatment. Our findings suggested the therapeutic potential of L. rhamnosus in OA.

Entities:  

Keywords:  Lactobacillus rhamnosus; inflammation; microbiota; monosodium iodoacetate (MIA); osteoarthritis

Year:  2021        PMID: 33946919     DOI: 10.3390/cells10051057

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  36 in total

Review 1.  Anabolic/Catabolic balance in pathogenesis of osteoarthritis: identifying molecular targets.

Authors:  Michael B Mueller; Rocky S Tuan
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 2.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

3.  The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial.

Authors:  M Lei; C Guo; D Wang; C Zhang; L Hua
Journal:  Benef Microbes       Date:  2017-07-20       Impact factor: 4.205

4.  Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo.

Authors:  E Miyauchi; H Morita; S Tanabe
Journal:  J Dairy Sci       Date:  2009-06       Impact factor: 4.034

Review 5.  Immunopathogenesis of osteoarthritis.

Authors:  Abdul Haseeb; Tariq M Haqqi
Journal:  Clin Immunol       Date:  2013-01-06       Impact factor: 3.969

Review 6.  Towards a better understanding of Lactobacillus rhamnosus GG--host interactions.

Authors:  Marijke E Segers; Sarah Lebeer
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

7.  Oral intake of Streptococcus thermophil us improves knee osteoarthritis degeneration: A randomized, double-blind, placebo-controlled clinical study.

Authors:  Jia-Ling Lyu; Ting-Ming Wang; Yen-Hao Chen; Shu-Ting Chang; Ming-Shiang Wu; Yung-Hao Lin; Yung-Hsiang Lin; Chen-Meng Kuan
Journal:  Heliyon       Date:  2020-04-25

8.  Exopolysaccharide from Lactobacillus rhamnosus KL37 Inhibits T Cell-dependent Immune Response in Mice.

Authors:  Bernadeta Nowak; Małgorzata Śróttek; Marta Ciszek-Lenda; Anna Skałkowska; Andrzej Gamian; Sabina Górska; Janusz Marcinkiewicz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-05-25       Impact factor: 4.291

Review 9.  Probiotics in Medicine: A Long Debate.

Authors:  Elisavet Stavropoulou; Eugenia Bezirtzoglou
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 10.  Gut-Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis.

Authors:  Alessandro de Sire; Roberto de Sire; Valentina Petito; Letizia Masi; Carlo Cisari; Antonio Gasbarrini; Franco Scaldaferri; Marco Invernizzi
Journal:  Nutrients       Date:  2020-02-22       Impact factor: 5.717

View more
  13 in total

1.  Coenzyme Q10 encapsulated in micelles ameliorates osteoarthritis by inhibiting inflammatory cell death.

Authors:  Hyun Sik Na; Jin Seok Woo; Ju Hwan Kim; Jeong Su Lee; In Gyu Um; Keun-Hyung Cho; Ga Hyeon Kim; Mi-La Cho; Sang J Chung; Sung-Hwan Park
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Probiotics Inhibit Cartilage Damage and Progression of Osteoarthritis in Mice.

Authors:  Antonia Sophocleous; Asim Azfer; Carmen Huesa; Eleni Stylianou; Stuart H Ralston
Journal:  Calcif Tissue Int       Date:  2022-10-19       Impact factor: 4.000

Review 3.  Therapeutic Anti-Depressant Potential of Microbial GABA Produced by Lactobacillus rhamnosus Strains for GABAergic Signaling Restoration and Inhibition of Addiction-Induced HPA Axis Hyperactivity.

Authors:  Fernanda-Marie Tette; Samuel K Kwofie; Michael D Wilson
Journal:  Curr Issues Mol Biol       Date:  2022-03-22       Impact factor: 2.976

Review 4.  Past, present, and future of cartilage restoration: from localized defect to arthritis.

Authors:  Dong Hwan Lee; Seok Jung Kim; Seon Ae Kim; Gang-Ik Ju
Journal:  Knee Surg Relat Res       Date:  2022-01-28

5.  The relation between the gut microbiome and osteoarthritis: A systematic review of literature.

Authors:  Emanuele Chisari; Marjan Wouthuyzen-Bakker; Alex W Friedrich; Javad Parvizi
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

6.  Quercetin modulates the gut microbiota as well as the metabolome in a rat model of osteoarthritis.

Authors:  Haifeng Lan; Wei Hong; Dongyang Qian; Fang Peng; Haiqing Li; Chunxiao Liang; Min Du; Jinlan Gu; Junxuan Mai; Bo Bai; Gongyong Peng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics.

Authors:  Zhentian Wei; Feng Li; Guofu Pi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

8.  Senkyunolide A inhibits the progression of osteoarthritis by inhibiting the NLRP3 signalling pathway.

Authors:  Minglei Shao; Dongwei Lv; Kai Zhou; Haijun Sun; Zhitao Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

9.  Reversing the surface charge of MSC-derived small extracellular vesicles by εPL-PEG-DSPE for enhanced osteoarthritis treatment.

Authors:  Kai Feng; Xuetao Xie; Ji Yuan; Liangzhi Gong; Zhaochen Zhu; Juntao Zhang; Haiyan Li; Yunlong Yang; Yang Wang
Journal:  J Extracell Vesicles       Date:  2021-11

Review 10.  Microbiota and Pain: Save Your Gut Feeling.

Authors:  Chiara Morreale; Ilia Bresesti; Annalisa Bosi; Andreina Baj; Cristina Giaroni; Massimo Agosti; Silvia Salvatore
Journal:  Cells       Date:  2022-03-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.